Why GoPro Shares Are Gaining Today
Why GoPro Shares Are Gaining Today
GoPro, Inc. (NASDAQ:GPRO) shares are trading higher on Tuesday.
週二,GoPro公司(納斯達克股票代碼:GPRO)股價上漲。
The company announced a fresh distribution collaboration with SoftBank Group's (OTC:SFTBY) SB C&S Corporation in Japan, leveraging one of the region's largest sales networks to market GoPro products.
該公司宣佈與日本軟銀集團(場外交易代碼:SFTBY)Sb C&S Corporation進行新的分銷合作,利用該地區最大的銷售網絡之一來銷售GoPro產品。
"Through SB C&S, we're continuing the expansion of our global retail presence, ensuring that GoPro products are more widely available to customers in Japan and improving our in-store merchandising and brand exposure," said Dean Jahnke, GoPro's Senior Vice President of Global Sales and Channel Marketing.
GoPro全球銷售和渠道營銷高級副總裁迪恩·賈恩克表示:“通過Sb C&S,我們將繼續擴大我們的全球零售業務,確保GoPro產品更廣泛地提供給日本客戶,並提高我們的店內銷售和品牌知名度。”
Also Read: Netflix 'Positively Positioned For Operating Momentum': Analyst Sees 'Normalization Of Streaming Wars'
另請閱讀:Netflix “爲運營勢頭做好了積極準備”:分析師認爲 “流媒體大戰正常化”
Under the agreement, SB C&S can now offer its retail customers in Japan the complete lineup of GoPro cameras and accessories, expanding access to the latest innovations and products from GoPro.
根據該協議,Sb C&S現在可以爲其日本的零售客戶提供完整的GoPro相機和配件陣容,從而擴大獲得GoPro最新創新和產品的機會。
SB C&S will distribute GoPro cameras and accessories across Japan, including SoftBank stores, Yodobashi, and Yamada.
Sb C&S將在日本各地分銷GoPro相機和配件,包括軟銀門店、澱橋店和山田店。
They'll enhance retail displays and offer training to improve customer shopping experiences for GoPro products.
他們將增強零售展示並提供培訓,以改善客戶對GoPro產品的購物體驗。
In May, the company announced a large-scale merchandising rollout and sales program at Best Buy Co., Inc. (NYSE:BBY).
5月,該公司宣佈在百思買公司(紐約證券交易所代碼:BBY)推出大規模銷售和銷售計劃。
Price Action: GPRO shares are trading higher by 7.39% to $1.525 at last check Tuesday.
價格走勢:週二最後一次檢查時,GPRO股價上漲7.39%,至1.525美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明:此內容部分是在人工智能工具的幫助下製作的,並由Benzinga的編輯審閱和發佈。
- This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
- 在推進ALS、阿爾茨海默氏症和帕金森氏病的基因治療計劃後,該醫療股在盤前飆升了80%以上